Gynaecological aspects of tamoxifen treatment in breast cancer patients
- PMID: 9465881
- DOI: 10.1016/s0305-7372(97)90029-3
Gynaecological aspects of tamoxifen treatment in breast cancer patients
Similar articles
-
Should tamoxifen users be screened for endometrial lesions?Lancet. 1998 Jan 17;351(9097):155-7. doi: 10.1016/S0140-6736(05)78216-7. Lancet. 1998. PMID: 9449866 No abstract available.
-
[Tamoxifen and breast cancer: is everything known already?].Tumori. 1998 Nov-Dec;84(6):A1-5. Tumori. 1998. PMID: 10080686 Review. Italian. No abstract available.
-
Second cancers after adjuvant tamoxifen therapy for breast cancer.J Natl Cancer Inst. 1996 Jun 19;88(12):832-4. doi: 10.1093/jnci/88.12.832. J Natl Cancer Inst. 1996. PMID: 8637050 No abstract available.
-
Tamoxifen and menopausal status: risks and benefits.Lancet. 1996 Mar 16;347(9003):761. doi: 10.1016/s0140-6736(96)90111-7. Lancet. 1996. PMID: 8602018 No abstract available.
-
Tamoxifen therapy--long-term results and complications.Adv Surg. 1996;29:263-9. Adv Surg. 1996. PMID: 8720007 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical